Teva Pharmaceutical reported 3.79B in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Aspen Pharmacare APN:SJ 19.38B 248M
Cipla CIPLA:IN IR 53751.9M 1148.6M
Dr.Reddys Laboratories DRRD:IN IR 52329M 2420M
Guangzhou Baiy 600332:CH CH 20538.51M 5064M
Jiangsu Hengrui Me. 600276:CH CH 5478.54M 228.02M
Kalbe Farma Tbk Pt KLBF:IJ RI 6858880.53M 156824.98M
Richter Gedeon RICHT:HB 192.92B 24.87B
Sh Fosun Pharma 600196:CH CH 10381.94M 1574.87M
Sun Pharmaceuticals SUNP:IN IR 107617.6M 13150M
Teva Pharmaceutical TEVA:IT 3.79B 125M